அலுவலகம் ஆஃப் சேர்க்கை ப்ராடக்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அலுவலகம் ஆஃப் சேர்க்கை ப்ராடக்ட்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அலுவலகம் ஆஃப் சேர்க்கை ப்ராடக்ட்ஸ் Today - Breaking & Trending Today

VIVOS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)


Message :
Required fields
Except for statements of historical fact, certain information described in this
Form 10-Q report contains forward-looking statements that involve substantial
risks and uncertainties. You can identify these statements by forward-looking
words such as anticipate, believe, could, estimate, expect, intend,
may, should, will, would or similar words. The statements that contain
these or similar words should be read carefully because these statements discuss
the Company s future expectations, including its expectations of its future
results of operations or financial position, or state other forward-looking
information.
Vivos Inc. believes that it is important to communicate its future
expectations to its investors. However, there may be events in the future that ....

United States , United Kingdom , State Of Washington , Washington State University , Great Britain , Albert Denittis , Alice Villalobos , Howard Sandler , Veterinary Medicine Product Classification Group , Company Isopet Solutions , Vivos Inc , National Cancer Institute , Company Radiogel , Pacific Northwest National Laboratory , Washington State Life Sciences Discovery Fund , Spectrum Pharmaceuticals , Battelle Memorial Institute , University Of Missouri , Colorado State University , International Search , Radiological Health , Department Of Health , Office Of Combination Products , American Veterinary Medical Association , American Cancer Society , Good Laboratory Practices ,

Aligning Combination Products Regulation In Asia-Pacific Distant Dream


By Dhiraj Behl Amity Institute of Pharmacy, Amity University, India, Janine Jamieson, International Pharmaceutical Quality, Sweden, and Harikesh Kalonia, Amity Institute of Pharmacy, Amity University, India
Innovative, integrated delivery devices are useful for vaccines as well as treatments required for cancer, heart disease, multiple sclerosis and many more serious and chronic diseases. Drug-device combination product types include the classic prefilled syringes and pens, auto-injectors, metered-dose inhalers, dry powder inhalers, and increasingly the inclusion of connected software. However, regulation of these products is complex.
Combination products (CP) such as these are governed by two or more different sets of regulations, based on their components and primary mode of action. This can lead to challenges for regulatory authorities to agree on product review jurisdiction and also how to streamline the drug and device requirements according to philosophy, documentati ....

Harikesh Kalonia , Janine Jamieson , Amity University , Amity Institute Of Pharmacy , Dhiraj Behl Amity Institute Of Pharmacy , Office Of Combination Products , International Pharmaceutical Quality , Dhiraj Behl Amity Institute , Amity Institute , Combination Products , நட்பு பல்கலைக்கழகம் , நட்பு நிறுவனம் ஆஃப் மருந்தகம் , அலுவலகம் ஆஃப் சேர்க்கை ப்ராடக்ட்ஸ் , சர்வதேச மருந்து தரம் , நட்பு நிறுவனம் , சேர்க்கை ப்ராடக்ட்ஸ் ,